These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10357392)

  • 1. Cytomegalovirus (re)activation plays no role in the ocular vitritis observed after initiation of highly active antiretroviral therapy.
    Boyraz-Ikiz HD; Witmer JP; Frissen PH
    AIDS; 1999 May; 13(7):867. PubMed ID: 10357392
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
    Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
    Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the benefits and limits of highly active antiretroviral therapy.
    D'Aquila R; Walker B
    JAMA; 1999 Nov; 282(17):1668-9. PubMed ID: 10553795
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune recovery vitritis in HIV infection: abstracts and commentary.
    Dunn JP
    JAMA; 1998 Jul; 280(2):185-6. PubMed ID: 9669796
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy.
    Jacobson MA; Stanley H; Holtzer C; Margolis TP; Cunningham ET
    Clin Infect Dis; 2000 Jan; 30(1):231-3. PubMed ID: 10619774
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.
    Karavellas MP; Plummer DJ; Macdonald JC; Torriani FJ; Shufelt CL; Azen SP; Freeman WR
    J Infect Dis; 1999 Mar; 179(3):697-700. PubMed ID: 9952380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR
    J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome.
    Karavellas MP; Lowder CY; Macdonald C; Avila CP; Freeman WR
    Arch Ophthalmol; 1998 Feb; 116(2):169-75. PubMed ID: 9488268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis.
    Zegans ME; Walton RC; Holland GN; O'Donnell JJ; Jacobson MA; Margolis TP
    Am J Ophthalmol; 1998 Mar; 125(3):292-300. PubMed ID: 9512145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL; Raboud J; Angel JB; Mazzulli T; Shen S; Casciaro L; Young CD; Moussa G; Gough K; Rachlis A; Hopkins J
    HIV Clin Trials; 2006; 7(1):1-9. PubMed ID: 16632459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune recovery vitritis presenting as panuveitis following therapy with protease inhibitors.
    Biswas J; Choudhry S; Kumarasamy ; Solomon S
    Indian J Ophthalmol; 2000 Dec; 48(4):313-5. PubMed ID: 11340892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of cytomegalovirus retinitis in an HIV-infected patient responsive to highly active antiretroviral therapy late after discontinuation of gancyclovir.
    Bertelli D; Stellini R; Cadeo GP
    AIDS; 1999 Sep; 13(13):1792-4. PubMed ID: 10509590
    [No Abstract]   [Full Text] [Related]  

  • 14. Discontinuation of maintenance CMV therapy in HAART responders.
    Dunn JP
    Hopkins HIV Rep; 1999 May; 11(3):5. PubMed ID: 11367373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Response to: Jeon and Lee's 'Cytomegalovirus Retinitis in a Human Immunodeficiency Virus-negative Cohort: Long-term Management and Complications'.
    Babu K; Sajid S
    Ocul Immunol Inflamm; 2017 Feb; 25(1):146-147. PubMed ID: 26943724
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS.
    Vitravene Study Group
    Am J Ophthalmol; 2002 Apr; 133(4):475-83. PubMed ID: 11931781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stricker RB; Goldberg B
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284794
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stein DS
    Lancet; 1997 Aug; 350(9077):589-90. PubMed ID: 9284796
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Mitchell SM; Youle MS; Membrey WL; Jones CD
    Lancet; 1997 Aug; 350(9077):588; author reply 590. PubMed ID: 9284792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.